Implantation devices including hydrogel filaments
US-2017007264-A1 · Jan 12, 2017 · US
US10226258B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10226258-B2 |
| Application number | US-201715635046-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 27, 2017 |
| Priority date | Jun 15, 2006 |
| Publication date | Mar 12, 2019 |
| Grant date | Mar 12, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Devices for the occlusion of body cavities, such as the embolization of vascular aneurysms and the like, and methods for making and using such devices. The devices may be comprised of novel expansile materials, novel infrastructure design, or both. The devices provided are very flexible and enable deployment with reduced or no damage to bodily tissues, conduits, cavities, etceteras.
Opening claim text (preview).
We claim: 1. An occlusion device comprising: an elongated hydrogel having a solid mass and a substantially continuous length, and a flexible carrier member situated around the elongated hydrogel, wherein the elongated hydrogel includes a polyether macromer, and wherein the elongated hydrogel is configured to expand upon contact with an aqueous liquid. 2. The occlusion device of claim 1 , wherein the polyether macromer is poly(ethylene glycol) di-acrylamide, poly(ethylene glycol) di-acrylate, poly(ethylene glycol) dimethacrylate, poly(ethylene glycol) dimethacrylamide, a derivative thereof, or a combinations thereof. 3. The occlusion device of claim 2 , wherein the polyether macromer is poly(ethylene glycol) di-acrylamide. 4. The occlusion device of claim 1 , wherein the flexible carrier member is a coil or microcoil. 5. The occlusion device of claim 1 , wherein the flexible carrier member includes at least one gap configured to allow the elongated hydrogel to expand into the at least one gap. 6. The occlusion device of claim 4 , wherein the at least one gap is between 0.00025″ and 0.005″. 7. The occlusion device of claim 1 , further comprising a monomer including at least one pH sensitive ionizable functional group. 8. The occlusion device of claim 7 , wherein the at least one pH sensitive ionizable functional group includes a basic group or an acidic group. 9. The occlusion device of claim 8 , wherein the basic group comprises an amine, derivatives thereof, or combinations thereof. 10. The occlusion device of claim 8 , wherein the basic group is configured to be deprotonated at pHs greater than the pKa or protonated at pHs less than the pKa of the functional group. 11. The occlusion device of claim 8 , wherein the acidic group comprises a carboxylic acid, derivatives thereof, or combinations thereof. 12. The occlusion device of claim 8 , wherein the acidic group is configured to be protonated at pHs less than the pKa or de-protonated at pHs greater than the pKa of the functional groups. 13. The occlusion device of claim 7 , wherein the monomer is acrylic acid, methacrylic acid, or a salt thereof. 14. The occlusion device of claim 1 , wherein the elongated hydrogel is substantially free of acrylamide. 15. The occlusion device of claim 1 , wherein the polyether macromer is cross-linked with at least one ethylenically unsaturated compound. 16. The occlusion device of claim 1 , wherein the polyether macromer is cross-linked with N,N′-methylenebisacrylamide, derivatives thereof, or combinations thereof. 17. The occlusion device of claim 1 , wherein the elongated hydrogel comprises a reaction product of a monomer, the polyether macromer, and an initiator. 18. The occlusion device of claim 17 , wherein the initiator is N,N,N′,N′-tetramethylethylenediamine, ammonium persulfate, azobisisobutyronitrile, benzoyl peroxides, 2,2′-azobis(2-methylpropionamidine) dihydrochloride, a derivative thereof, or a combination thereof. 19. The occlusion device of claim 1 , wherein the elongated hydrogel is substantially non-resorbable. 20. The occlusion device of claim 1 , wherein the flexible carrier member is metallic or polymeric. 21. The occlusion device of claim 1 , wherein the elongated hydrogel includes pores.
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title
having a pre-set deployed three-dimensional shape (methods of manufacturing A61B2017/00526) · CPC title
having a mesh structure (A61B17/1214 takes precedence) · CPC title
within an aneurysm · CPC title
Coils or wires · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.